Lyell Immunopharma, Inc.
General ticker "LYEL" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $155.9M (TTM average)
Lyell Immunopharma, Inc. follows the US Stock Market performance with the rate: 46.3%.
Estimated limits based on current volatility of 8.7%: low 21.78$, high 25.94$
Factors to consider:
- Total employees count: 300 (+33.9%) as of 2024
- Top business risk factors: Insufficient funding, Labor/talent shortage/retention, Market volatility, Product commercialization failure, Market competition
Short-term LYEL quotes
Long-term LYEL plot
Financial data not available